MediNatura New Mexico is recalling a homeopathic nasal spray due to microbial contamination with yeast, mold, and ...

As the world’s population becomes more connected, the WHO has reaffirmed its global strategy to boost the use of digital health tools.

A widely used blood pressure medication is being pulled from shelves after testing suggested some batches may contain traces of other drugs.

The ACIP votes to allow parental choice regarding the timing and necessity of the hepatitis B vaccine for newborns.

Medical influencers and social media, having changed the ways in which physicians communicate, now carry certain ethical responsibilities.

Fatty acid abnormalities and EFAD biomarkers are common in patients with cystic fibrosis who have severe CFTR genotypes.

Adjunct corticosteroids probably reduce short-term mortality in adults with severe pneumonia or acute respiratory distress syndrome.

A new alert from the FDA warns that some sensors from Abbott may give incorrect blood sugar readings, which could lead to unsafe treatment decisions.

A newly developed primary care clinical pathway for bronchiolitis management in young children successfully reduced bronchodilator and steroid use.

Drug–induced liver injury appears more common in patients on tuberculosis therapy with chronic hepatitis C virus infection.

CHEST guidelines on biologic management in severe adult asthma offers recommendations on choosing and switching among biologic therapies.

The FDA is facing even more leadership changes as drug regulator Dr Richard Pazdur prepares to retire at the end of the month.